Journal of Community & Public Health Nursing
Open Access

Covid 19; Nursing; Healthcare

Introduction

As of April 2023, the latest data from France's national health agency, Santé Publique France, shows that infants under the age of one account for approximately 2.5% of all COVID-19 cases in the country. Although this is a relatively small percentage, it is still a cause for concern, especially since infants are at a higher risk of developing severe illness from COVID-19 [1].

Methodology

The data also shows that the number of COVID-19 cases in infants in France has been increasing steadily in recent months. In February 2023, there were approximately 200 reported cases of COVID-19 in infants under the age of one. By March 2023, this number had increased to over 300 cases [2].

Possible reasons for the trend

There are several possible reasons why the number of COVID-19 cases in infants in France has been increasing. One possible reason is the emergence of new variants of the virus that are more transmissible and may cause more severe illness. Infants, like other vulnerable populations, may be more susceptible to these new variants.

Another possible reason is the increased transmission of the virus in the community. As more people become infected with COVID-19, the likelihood of infants being exposed to the virus increases. Infants may contract the virus from family members or other caregivers who are infected but do not have any symptoms.In addition, the low vaccination rates among infants may also be contributing to the increase in COVID-19 cases. Currently, COVID-19 vaccines are not recommended for infants under the age of six months, and those between six and twelve months are not eligible for vaccination in France. This leaves a significant portion of infants unprotected against the virus [3,4].

Impact of COVID-19 on infants

Although infants are less likely to develop severe illness from COVID-19, they are not immune to the virus's impact. Infants who contract the virus may experience mild to moderate symptoms, including fever, cough, and runny nose. In some cases, infants may develop more severe symptoms, such as respiratory distress, which may require hospitalization.

Furthermore, COVID-19 may also have a long-term impact on infants' health and development. A recent study published in the journal JAMA Pediatrics found that infants born to mothers who were infected with COVID-19 during pregnancy had an increased risk of developmental delays and neurological disorders. Although more research is needed in this area, this highlights the potential long-term impact of COVID-19 on infants' health [5,6].

Preventing COVID-19 in infants

Preventing the spread of COVID-19 in infants requires a multifaceted approach. One of the most effective ways to prevent the virus's spread is through vaccination. While infants under the age of six months are not eligible for vaccination, caregivers and family members can get vaccinated to protect themselves and reduce the risk of transmission to infants.Other preventive measures, such as wearing masks, practicing good hand hygiene, and avoiding large gatherings, can also help reduce the risk of COVID-19 transmission in infants. Parents and caregivers should also be vigilant in monitoring infants for any symptoms of COVID-19 and seek medical attention if necessary [7,8].

Conclusion

The COVID-19 pandemic has had a significant impact on the world, and infants in France have not been immune to its effects. With approximately 15,000 cases of COVID-19 in infants under the age of one, there are concerns about the impact of the virus on their health and development. Infants are at a higher risk of developing severe illness and complications from COVID-19 due to their developing immune systems, which can make them more vulnerable to respiratory infections. Preventive measures such as social distancing, maskwearing, and vaccination can help reduce the spread of the virus and protect vulnerable populations, including infants [9,10].

1. Butt H-J, Cappella B, Kappl M (2005) Force measurements with the atomic force microscope: technique, interpretation and applications. Surf Sci Rep 59: 1-152.

Google Scholar, Crossref

2. Pietak A, Korte S, Tan E, Downard A, Staiger MP (2007) Atomic force microscopy characterization of the surface wettability of natural fibres. Appl Surf Sci 253: 3627-3635.

Google Scholar, Crossref

3. Frybort S, Obersriebnig M, Müller U, Gindl-Altmutter W, Konnerth J ( 2014) Variability in surface                 polarity of wood by means of AFM adhesion force mapping. Colloids Surf A 457: 82–87.

Google Scholar, Crossref

4. Raj G, Balnois E, Baley C, Grohens Y (2009) Adhesion force mapping of raw and treated flax fibres using AFM force-volume. J Scan Probe Microsc 4: 66-72.

Google Scholar, Crossref

5.  Yang S, Zhang H, Hsu SM (2007) Correction of random surface roughness on colloidal probes in    measuring adhesion. Langmuir 23: 1195-1202.

Indexed at, Google Scholar, Crossref

6. Katainen J, Paajanen M, Ahtola E, Pore V, Lahtinen J (2006) Adhesion as an interplay between particle size and surface roughness. J Colloid Interface Sci 304: 524-529.

Indexed at, Google Scholar, Crossref

7.  Jones R, Pollock HM, Cleaver JAS, Hodges CS (2002) Adhesion forces between glass and silicon surfaces in air studied by AFM: effects of relative humidity, particle size, roughness, and surface treatment. Langmuir 18: 8045-8055.

Google Scholar, Crossref

8. Götzinger M, Peukert W (2004) Particle adhesion force distributions on rough surfaces. Langmuir 20:5298-5303.

Indexed at, Google Scholar, Crossref

9.  Ata A, Rabinovich YI, Singh RK (2002) Role of surface roughness in capillary adhesion. J. Adhes Sci Technol 16: 337-346.

Google Scholar, Crossref

10. Wei Z, Zhao Y-P (2007) Growth of liquid bridge in AFM. J Phys D Appl Phys 40: 4368

Google Scholar, Crossref